نتائج البحث

Therapeutic targets in myeloma bone disease.

• Authors : Marino S; Department of Medicine, Division Hematology/Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.; Petrusca DN

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Multiple Myeloma*/Multiple Myeloma*/Multiple Myeloma*/drug therapy ; Osteolysis*

• Source: British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (9), pp. 1907-1922. Date of Electronic Publication: 2020 Feb 03.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Overview of treatment approaches to osteoporosis.

• Authors : Langdahl BL; Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark.

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Osteoporosis*/Osteoporosis*/Osteoporosis*/drug therapy; Bone Density

• Source: British journal of pharmacology [Br J Pharmacol] 2021 May; Vol. 178 (9), pp. 1891-1906. Date of Electronic Publication: 2020 Mar 20.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Safety Profiles, Pharmacokinetics, and Changes in Bone Turnover Markers After Twice-Weekly Subcutaneous Administration of Teriparatide in Healthy Japanese Postmenopausal Women: A Single-Blind Randomized Study.

• Authors : Kumagai Y; Kitasato University East Hospital, Kanagawa, Japan.; Ose A

Subjects: Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Teriparatide/Teriparatide/Teriparatide/*administration & dosage; Aged

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2020 Jan; Vol. 9 (1), pp. 87-96. Date of Electronic Publication: 2019 Mar 28.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Adjuvant bisphosphonate therapy in early-stage breast cancer-Treating the soil to kill the seed.

• Authors : Brufsky A; University of Pittsburgh Cancer Institute, Magee-Women's Hospital, Pittsburgh, Pennsylvania.; Mathew A

Subjects: Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Bone Neoplasms/Bone Neoplasms/Bone Neoplasms/*secondary ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

• Source: The breast journal [Breast J] 2020 Jan; Vol. 26 (1), pp. 65-68. Date of Electronic Publication: 2019 Dec 26.Publisher: Wiley Country of Publication: United States NLM ID: 9505539 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone.

• Authors : Panwar P; Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, BC, Canada.; Centre for Blood Research, Vancouver, BC, Canada.

Subjects: Abietanes/Abietanes/Abietanes/*pharmacology ; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*pharmacology ; Bone Resorption/Bone Resorption/Bone Resorption/*prevention & control

• Source: British journal of pharmacology [Br J Pharmacol] 2018 Mar; Vol. 175 (6), pp. 902-923. Date of Electronic Publication: 2018 Feb 09.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Italian position paper (SIPMO‐SICMF) on medication‐related osteonecrosis of the jaw (MRONJ)

• Authors : Bedogni Alberto; Mauceri Rodolfo; Fusco Vittorio ...

Subjects: Denosumab; MRONJ; ONJ

تفاصيل العنوان

Effects of different forages on the chemical compositions and antiosteoporotic activities of velvet antlers.

• Authors : Tseng SH; School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Orthopedics Research Center, Taipei Medical University Hospital, Taipei, Taiwan.

Subjects: Bone Density Conservation Agents* ; Deer*; Animal Feed/Animal Feed/Animal Feed/*classification

• Source: Animal science journal = Nihon chikusan Gakkaiho [Anim Sci J] 2016 Aug; Vol. 87 (8), pp. 989-96. Date of Electronic Publication: 2015 Nov 26.Publisher: Wiley Country of Publication: Australia NLM ID: 100956805 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Vitamin D, osteoprotegerin/receptor activator of nuclear factor-kappaB ligand (OPG/RANKL) and inflammation with alendronate treatment in HIV-infected patients with reduced bone mineral density.

• Authors : Natsag J; Division of Endocrinology, Diabetes & Metabolism, Johns Hopkins University, Baltimore, MD, USA.; Kendall MA

Subjects: Alendronate/Alendronate/Alendronate/*administration & dosage ; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Bone Resorption/Bone Resorption/Bone Resorption/*drug therapy

• Source: HIV medicine [HIV Med] 2016 Mar; Vol. 17 (3), pp. 196-205. Date of Electronic Publication: 2015 Jul 16.Publisher: Wiley Country of Publication: England NLM ID: 100897392 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

A double-blind, randomized, ascending, multiple-dose study of bazedoxifene in healthy postmenopausal women.

• Authors : McKeand WE; Pfizer Inc, Collegeville, PA, USA.; Orczyk GP

Subjects: Postmenopause*; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*administration & dosage ; Indoles/Indoles/Indoles/*administration & dosage

• Source: Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2014 Jul; Vol. 3 (4), pp. 262-9. Date of Electronic Publication: 2014 Feb 09.Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

• Authors : Zhai ZJ; Shanghai Key Laboratory of Orthopaedic Implants, Department of Orthopaedics, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Li HW

Subjects: Disease Models, Animal*; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*therapeutic use ; Diterpenes/Diterpenes/Diterpenes/*therapeutic use

• Source: British journal of pharmacology [Br J Pharmacol] 2014 Feb; Vol. 171 (3), pp. 663-75.Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان